Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Glycan antagonists and inhibitors: a fount for drug discovery.

Brown JR, Crawford BE, Esko JD.

Crit Rev Biochem Mol Biol. 2007 Nov-Dec;42(6):481-515. Review.

PMID:
18066955
2.

Chemical and enzymatic release of glycans from glycoproteins.

Merry T, Astrautsova S.

Methods Mol Biol. 2003;213:27-40. Review. No abstract available.

PMID:
12619983
3.

Chemistry of natural glycan microarrays.

Song X, Heimburg-Molinaro J, Cummings RD, Smith DF.

Curr Opin Chem Biol. 2014 Feb;18:70-7. doi: 10.1016/j.cbpa.2014.01.001. Epub 2014 Jan 30. Review.

4.

Glycan-based high-affinity ligands for toxins and pathogen receptors.

Kulkarni AA, Weiss AA, Iyer SS.

Med Res Rev. 2010 Mar;30(2):327-93. doi: 10.1002/med.20196. Review.

PMID:
20135686
5.

Informatic innovations in glycobiology: relevance to drug discovery.

Mamitsuka H.

Drug Discov Today. 2008 Feb;13(3-4):118-23. doi: 10.1016/j.drudis.2007.10.013. Epub 2007 Nov 26. Review.

PMID:
18275909
6.

Functional glycomics and glycobiology: an overview.

Li J, Richards JC.

Methods Mol Biol. 2010;600:1-8. doi: 10.1007/978-1-60761-454-8_1. Review.

PMID:
19882117
7.

Glycosylated-phosphatidylinositols as virulence factors in Leishmania.

McConville MJ.

Cell Biol Int Rep. 1991 Sep;15(9):779-98. Review. No abstract available.

PMID:
1802411
8.

Galactofuranose in eukaryotes: aspects of biosynthesis and functional impact.

Tefsen B, Ram AF, van Die I, Routier FH.

Glycobiology. 2012 Apr;22(4):456-69. doi: 10.1093/glycob/cwr144. Epub 2011 Sep 22. Review.

PMID:
21940757
9.

Glycoscience -- a new frontier in rational drug design.

Gornik O, Dumić J, Flogel M, Lauc G.

Acta Pharm. 2006 Mar;56(1):19-30. Review.

PMID:
16613732
10.

[Complex carbohydrates: their biosynthesis and biological role in the animal cell].

Vidershaĭn GIa.

Mol Biol (Mosk). 1976 Sep-Oct;10(5):957-80. Review. Russian.

PMID:
802779
11.

Bioinformatics approaches in glycomics and drug discovery.

Aoki-Kinoshita KF, Kanehisa M.

Curr Opin Mol Ther. 2006 Dec;8(6):514-20. Review.

PMID:
17243487
12.

Chemical tools for functional studies of glycans.

Park S, Lee MR, Shin I.

Chem Soc Rev. 2008 Aug;37(8):1579-91. doi: 10.1039/b713011m. Epub 2008 Jun 9. Review.

PMID:
18648683
13.

Emerging principles for the therapeutic exploitation of glycosylation.

Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA.

Science. 2014 Jan 3;343(6166):1235681. doi: 10.1126/science.1235681. Review.

PMID:
24385630
14.

Glycomics-driven discoveries in schistosome research.

Hokke CH, Deelder AM, Hoffmann KF, Wuhrer M.

Exp Parasitol. 2007 Nov;117(3):275-83. Epub 2007 Jun 17. Review.

PMID:
17659278
15.

Biosynthesis of 6-deoxyhexose glycans in bacteria.

Mäki M, Renkonen R.

Glycobiology. 2004 Mar;14(3):1R-15R. Epub 2003 Dec 23. Review.

PMID:
14693916
16.

Chemical probing of glycans in cells and organisms.

Rouhanifard SH, Nordstrøm LU, Zheng T, Wu P.

Chem Soc Rev. 2013 May 21;42(10):4284-96. doi: 10.1039/c2cs35416k. Epub 2012 Dec 21. Review.

17.

Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.

Lu H, Tonge PJ.

Acc Chem Res. 2008 Jan;41(1):11-20. doi: 10.1021/ar700156e. Review.

PMID:
18193820
18.

Importance of N-glycosylation on alpha5beta1 integrin for its biological functions.

Gu J, Isaji T, Sato Y, Kariya Y, Fukuda T.

Biol Pharm Bull. 2009 May;32(5):780-5. Review.

19.

The repertoire of glycan determinants in the human glycome.

Cummings RD.

Mol Biosyst. 2009 Oct;5(10):1087-104. doi: 10.1039/b907931a. Epub 2009 Jul 28. Review.

PMID:
19756298
20.

From structural to functional glycomics: core substitutions as molecular switches for shape and lectin affinity of N-glycans.

André S, Kozár T, Kojima S, Unverzagt C, Gabius HJ.

Biol Chem. 2009 Jul;390(7):557-65. doi: 10.1515/BC.2009.072. Review.

PMID:
19426132

Supplemental Content

Support Center